期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

酪氨酸激酶抑制剂致慢性髓系白血病患者乙肝再激活1例并文献复习 被引量：4

下载PDF
导出
摘要 0引言酪氨酸激酶抑制剂(tyrosine kinase inhibitor,TKI)作为一类针对酪氨酸激酶的分子靶向治疗药物,已成为慢性髓系白血病(chronic myelogenous leukemia,CML)患者药物治疗的首选。近年来出现了合并慢性HBV感染的CML患者接受TKI治疗后发生乙肝再激活的报道,引起医疗工作者对该药物靶向外不良反应的关注。基于此,
作者 赵攀 谭竞 魏锦
机构地区 川北医学院附属医院血液科
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2015年第1期90-92,共3页 Cancer Research on Prevention and Treatment
基金 四川省教育厅重点项目(13ZA0233)
关键词 乙型肝炎病毒 再激活 酪氨酸激酶抑制剂 慢性髓系白血病
分类号 R733.72 [医药卫生—肿瘤]
  • 相关文献

参考文献16

  • 1Guan-Min Lai,Sheng-Lei Yan,Cheng-Shyong Chang,Chien-Yu Tsai.Hepatitis B reactivation in chronic myeloid leukemia patients receiving tyrosine kinase inhibitor[J].World Journal of Gastroenterology,2013,19(8):1318-1321. 被引量：6
  • 2Jing Tan,Jingguo Zhou,Pan Zhao,Jing Wei.Prospective study of HBV reactivation risk in rheumatoid arthritis patients who received conventional disease-modifying antirheumatic drugs[J]. Clinical Rheumatology . 2012 (8)
  • 3Yeo W,Chan PK,Zhong S,et al.Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factors. Journal of Medical Virology . 2000
  • 4Mumprecht Sabine,Matter Matthias,Pavelic Viktor,Ochsenbein Adrian F.Imatinib mesylate selectively impairs expansion of memory cytotoxic T cells without affecting the control of primary viral infections. Blood . 2006
  • 5Ruth Seggewiss,Karin Loré,Elisabeth Greiner,Magnus K. Magnusson,David A. Price,Daniel C. Douek,Cynthia E. Dunbar,Adrian Wiestn.Imatinib inhibits T-cell receptor?mediated T-cell proliferation and activation in a dose-dependent manner. Blood . 2005
  • 6Parisa Sinai,Rance E. Berg,J. Marshall Haynie,Merrill J. Egorin,Robert L. Ilaria,Jr,James Form.Imatinib Mesylate Inhibits Antigen-Specific Memory CD8 T Cell Responses In Vivo. J. Immunol . 2007
  • 7S.G. Kim,J.M. Chun,R. Jin,J.Y. Kim,D.I. Won,Y.J. Hwang.Living Donor Liver Transplantation for Acute Hepatic Failure Caused by Reactivation of Hepatitis B Virus Infection After Chemotherapy for Hematologic Malignancy: Case Reports[J]. Transplantation Proceedings . 2010 (3)
  • 8Yoshiki Hayashi,Hirohisa Nakamae,Takako Katayama,Takahiko Nakane,Hideo Koh,Mika Nakamae,Asao Hirose,Kiyoyuki Hagihara,Yoshiki Terada,Yoshitaka Nakao,Masayuki Hino.Different immunoprofiles in patients with chronic myeloid leukemia treated with imatinib, nilotinib or dasatinib[J]. Leukemia & Lymphoma . 2012 (6)
  • 9K. Ikeda,Y. Shiga,A. Takahashi,T. Kai,H. Kimura,K. Takeyama,H. Noji,K. Ogawa,A. Nakamura,H. Ohira,Y. Sato,Y. Maruyama.Fatal hepatitis B virus reactivation in a chronic myeloid leukemia patient during imatinib mesylate treatment[J]. Leukemia & Lymphoma . 2006 (1)
  • 10Byung Woog Kang,Soo Jung Lee,Joon Ho Moon,Shi-Nae Kim,Yee Soo Chae,Jong Gwang Kim,Yoon-Jin Hwang,Sang-Kyun Sohn.Chronic myeloid leukemia patient manifesting fatal hepatitis B virus reactivation during treatment with imatinib rescued by liver transplantation: case report and literature review[J]. International Journal of Hematology . 2009 (3)

二级参考文献49

  • 1Flink HJ,van Zonneveld M,Hansen BE,陆伟（摘译）,张占卿（审校）.聚乙二醇化干扰素a-2b治疗HBeAg阳性慢性乙型肝炎：HBsAg转阴与HBV基因型相关[J].世界感染杂志,2006,6(4):357-357. 被引量：46
  • 2Yeo W, Johnson PJ. Diagnosis, prevention and management of hep- atitis B virus reactivation during anticaneer therapy. Hepatology, 2006, 43:209-220.
  • 3Ikeda K, Shiga Y, Takahashi A, et al. Fatal hepatitis B virus re- activation in a chronic myeloid leukemia patient during imatinib mesylate treatment. Leuk Lymphoma, 2006,47 : 155-157.
  • 4Thia TJ, Tan HH, Chuah TH, et al. Imatinib mesylate-related fa- tal acute hepatic failure in a patient with chronic myeloid leukae- mia and chronic hepatitis B infection. Singapore Med J, 2008, 49 : e86-89.
  • 5Kang BW, Lee SJ, Moon JH, et al. Chronic myeloid leukemia pa- tient manifesting fatal hepatitis B virus reactivation during treat- ment with imatinib rescued by liver transplantation: case report and literature review, lnt J l-Iematol, 2009,90:383-387.
  • 6Kim SG, Chun JM, Jin R, et al. Living donor liver transplantation for acute hepatic failure caused by reactivation of hepatitis B virus infection after chemotherapy for hematologic malignancy: case re- ports. Transplant Proc, 2010, 42:843-845.
  • 7Lakhani S, Davidson L, Priebat D, et al. Reactivation of chronic hepatitis B infection related to imatinib mesylate therapy. Hepatol Int, 2008, 2:498-499.
  • 8Druker BJ, Talpaz M, Resta DJ, et al. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic mye- Ioid leukemia. N Eng! J Med, 2001, 344:1031-1037.
  • 9James C, Trouette H, Marit G, et al. Histological features of acute hepatitis after Imatinib mesylate treatment. Leukemia, 2003, 17 : 978-979.
  • 10Yeo W, Chan PK, Zhong S, et al. Frequency of hepatitis B virusreactivation in cancer patients undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk fac- tors. J Med Virol, 2000, 62: 299-307.

共引文献76

同被引文献30

引证文献4

二级引证文献13

肿瘤防治研究
2015年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部